Stanford University
Showing 191-200 of 360 Results
-
Shachar Lev Ari
Visiting Instructor/Lecturer, Genetics
BioI am a member and former Chair of the Department of Health Promotion, in the School of Public Health, in the Faculty of Medicine at Tel-Aviv University, former director, and founder of the Integrative Medicine Center & Research Laboratory at the Tel- Aviv Medical Center, and Head of the Health Promotion Unit in the Integrated Cancer Prevention Center. My training is in cellular biology, integrative medicine, intervention research, and health promotion science. I received the Outstanding Israeli Researcher for Complementary and Integrative Medicine award. The goal of my research is to unravel the biology, physiology, and psychology of health promotion approaches and translate findings into interventions that effectively target salutogenic mechanisms underpinning the biopsychology of well-being. I initiated the "lasting change" study and will co-lead this project in my current role as visiting scholar, at Prof. Michael Snyder's Lab, a global leader in precision health at Stanford University.
https://en.wikipedia.org/wiki/Shahar_Lev-Ari -
Jin Billy Li
Professor of Genetics
Current Research and Scholarly InterestsThe Li Lab is primarily interested in RNA editing mediated by ADAR enzymes. We co-discovered that the major function of RNA editing is to label endogenous dsRNAs as "self" to avoid being recognized as "non-self" by MDA5, a host innate immune dsRNA sensor, leading us to pursue therapeutic applications in cancer, autoimmune diseases, and viral infection. The other major direction of the lab is to develop technologies to harness endogenous ADAR enzymes for site-specific transcriptome engineering.
-
Wen-yang Lin
Postdoctoral Scholar, Genetics
Current Research and Scholarly InterestsThe broad goal of my research interest is to identify intrinsic and extrinsic mediators of tumor growth and plasticity. My past research experiences will synergize with the expertise of Dr. Monte Winslow’s laboratory to allow the discovery of novel mechanisms of cancer progression. The integration of our molecular measurements with multiple types of ‘omics’ data will ultimately improve the diagnostic precision medicine.
